Bayer’s finerenone gets FDA nod for diabetic kidney diseaseBayer’s big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in Share XBayer’s finerenone gets FDA nod for diabetic kidney diseasehttps://pharmaphorum.com/news/bayers-finerenone-gets-fda-nod-for-diabetic-kidney-disease/
Bayer data for kidney disease hope finerenone sets up filingsBayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication Share XBayer data for kidney disease hope finerenone sets up filingshttps://pharmaphorum.com/news/bayer-data-for-kidney-disease-hope-finerenone-sets-up-filings/
